Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Accolade Inc (NQ: ACCD )

10.76 -0.14 (-1.28%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Accolade Inc

< Previous 1 2 3 4 5 6 Next >
Accolade Posts Narrower Quarterly Loss, Tightens Annual Sales Guidance
Via Benzinga
Accolade Announces Results for Fiscal Second Quarter 2023
From Accolade, Inc.
Via GlobeNewswire
Earnings Scheduled For October 6, 2022
Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.52 per share on revenue of $2.85 billion. 
Via Benzinga
Accolade Earnings Preview
Accolade (NASDAQ:ACCD) is set to give its latest quarterly earnings report on Thursday, 2022-10-06. Here's what investors need to know before the announcement. Analysts estimate that Accolade will... 
Via Benzinga
Analyst Ratings for Accolade
Accolade (NASDAQ:ACCD) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Analyst Ratings for Accolade
Accolade (NASDAQ:ACCD) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Here's Why Accolade Shares Are Trading Higher Today
Via Benzinga
Accolade Shares Slip After Q1 Results, Guides Q2 Revenue Below Consensus
Via Benzinga
Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session
Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday. 
Via Benzinga
Delta Air Lines To Rally Around 84%? Here Are 5 Other Price Target Changes For Tuesday
Raymond James raised Delta Air Lines, Inc. (NYSE: DAL) price target from $50 to $52. Raymond James analyst Savanthi Syth maintained a Strong Buy rating on the stock. Delta Air shares rose 0.7% to close... 
Via Benzinga
Alphabet To $114? Plus This Analyst Predicts $145 For Disney
B of A Securities cut Alphabet Inc. (NASDAQ: GOOGL) price target from $125 to $114. Alphabet shares rose 1.9% to $100.50 in pre-market trading. 
Via Benzinga
Wells Fargo Slashes Price Target On This Stock By Over 71%, Also Check Out Other Major PT Changes Here
Wells Fargo cut the price target on Cabaletta Bio, Inc. (NASDAQ: CABA) from $14 to $4. Wells Fargo analyst Derek Archila maintained the stock with an Overweight rating. Cabaletta Bio shares gained 0.9%... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022
  
Via Benzinga
Where Accolade Stands With Analysts
  Over the past 3 months, 5 analysts have published their opinion on Accolade (NASDAQ:ACCD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Priority Health announces launch of new health navigation solution, PriorityGPS™
From Priority Health
Via Business Wire
This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday
Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market. 
Via Benzinga
U.S Stocks Turn Lower; Dow Tumbles Over 100 Points
U.S. stocks turned lower midway through trading, with the Dow Jones dropping more than 100 points on Friday. 
Via Benzinga
This EV Maker Stock Jumps More Than 9%, Here's 46 Stocks Moving In Thursday's Mid-Day Session
Gainers United Maritime Corporation (NASDAQ: USEA) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday after completing its spin-off from Seanergy Maritime Holdings Corp. 
Via Benzinga
Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 56.1% to $ 0.7029 after dropping 10% on Thursday. 
Via Benzinga
Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday
Gainers Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64. Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday. 
Via Benzinga
10 Analysts Have This to Say About Accolade
Over the past 3 months, 10 analysts have published their opinion on Accolade (NASDAQ:ACCD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Accolade Moves Higher But Growth Is Slowing
Accolade (NASDAQ: ACCD) is certainly an interesting play on the health care space providing business and employee services geared toward helping clients navigate the cumbersome health benefits arena.... 
Via MarketBeat
U.S. Stock Futures Edge Lower Ahead Of Manufacturing Data
Pre-open movers U.S. stock futures traded slightly lower in early pre-market trade on Friday after the Wall Street recorded its worst first half in over 50 years. 
Via Benzinga
Micron, Akebia Therapeutics And 3 Stocks To Watch Heading Into Friday
Some of the stocks that may grab investor focus today are: 
Via Benzinga
Earnings Scheduled For June 30, 2022
Companies Reporting Before The Bell • Tsakos Energy Navigation (NYSE:TNP) is expected to report quarterly loss at $0.21 per share on revenue of $152.71 million. 
Via Benzinga
Earnings Preview For Accolade
Accolade (NASDAQ:ACCD) is set to give its latest quarterly earnings report on Thursday, 2022-06-30. Here's what investors need to know before the announcement. Analysts estimate that Accolade will... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.3% to $1.03 during Wednesday's after-market session. The company's market cap stands at $33.2 million. 
Via Benzinga
NASDAQ: ACCD Investor Alert: Investigation over Potential Wrongdoing at Accolade, Inc.
San Diego, CA -- (SBWIRE) -- 06/16/2022 -- An investigation on behalf of investors in Accolade, Inc. (NASDAQ: ACCD) shares over potential wrongdoing at Accolade, Inc. was announced. 
Via SBWire
NASDAQ:ACCD Shareholder Notice: Investigation over Potential Securities Laws Violations by Accolade, Inc.
San Diego, CA -- (SBWIRE) -- 05/10/2022 -- An investigation was announced over potential securities laws violations by Accolade, Inc. in connection with certain financial statements. 
Via SBWire
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.